---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-043724"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2026-09-22T21:00:16+00:00"
generated_at: "2026-09-22T21:02:27.627591+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics raises $1.2M in registered direct offering of 1,025,640 shares

## Summary
- 1,025,640 shares sold at $1.17/share; gross proceeds ~$1.2M.
- Offering closed Sept 21, 2026; no underwriter, placement agent, or discounts.
- Net proceeds for working capital and general corporate purposes.
- Directors and executive officers subject to 60-day lock-up; company agreed to 45-day equity standstill.
- Shares offered via effective Form S-3 shelf (File No. 333-282456).

## SEC filing metadata
- accession: 0001493152-26-043724
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2026-09-22T21:00:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315226043724/0001493152-26-043724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315226043724/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-043724
- JSON: https://secwatch.observer/filing/0001493152-26-043724.json
- Plain text: https://secwatch.observer/filing/0001493152-26-043724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.